Policy

Kevin Fowler speaks about patient engagement in scholarly publishing

Kidney News Online reached out to Kevin Fowler to speak about his upcoming talk on how CJASN has incorporated Patient Voice into a monthly feature in the journal at the 2019 Council of Science Editors Annual Meeting on the topic of “Patient Engagement in Scholarly Publishing” on May 6th in Columbus, OH.

Kevin Fowler speaks about patient engagement in scholarly publishing

Kidney News Online reached out to Kevin Fowler to speak about his upcoming talk on how CJASN has incorporated Patient Voice into a monthly feature in the journal at the 2019 Council of Science Editors Annual Meeting on the topic of “Patient Engagement in Scholarly Publishing” on May 6th in Columbus, OH. Mr.

2019 Global Kidney Health Atlas released at ISN Word Congress

The Atlas found that “by 2030, 14.5 million people around the world will have end-stage kidney disease (ESKD), yet only 5.4 million will be treated due to economic, social, and political factors. Additionally, more than 2 million people will die each year to due to little or no access to hemodialysis or kidney transplantation”.

American Society of Nephrology Announces KidneyX Chair

The American Society of Nephrology (ASN) announced today that John R. Sedor, MD, FASN, has been appointed Chair of the Kidney Innovation Accelerator (KidneyX) Steering Committee.logo_big_0.png

CMS: Open Payments Pre-publication Review and Dispute Now Available

Pre-publication review and dispute for the Program Year 2018 Open Payments data is available beginning today April 1, 2019 through May 15, 2019. The Centers for Medicare & Medicaid Services (CMS) will publish the Open Payments Program Year 2018 data and updates to the previous program years’ data in June 2019

Physician and teaching hospital review of the data is voluntary, but strongly encouraged. Please keep in mind the following:

KidneyX Scores Major Victories in Congress and Administration

At the urging of the American Society of Nephrology (ASN) members and American Association of Kidney Patients (AAKP) ambassadors’ calls and recent visits to Capitol Hill, a bipartisan group of 57 lawmakers wrote to the House Appropriations Labor, Health and Human Services, and Education Subcommittee asking them to include $25 million in funding for KidneyX.

Innovative New Kidney Care Model in Development Highlighted at National Quality Forum

In a packed session of the National Quality Forum (NQF) in Washington, DC today, Adam Boehler, Deputy Administrator for CMS and Director and the Center for Medicare and Medicaid Innovation (CMMI), spoke about an upcoming comprehensive kidney care model being developed by CMMI and written about previously in KNO – as well as his vision of the role of quality and quality measurement in healthcare overall.

ASN and AAKP Advocates Are on Capitol Hill Urging Congress to Support KidneyX

Advocates from the American Society of Nephrology (ASN) and the American Association of Kidney Patients (AAKP) are meeting with representatives, senators, and their respective staffs today, March 20th, to urge Congress to support KidneyX, a public-private partnership to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.

In Case You Missed It: Top 20 Ways ASN is Increasing Interest in Nephrology Careers

March is National Kidney Month and to celebrate, Kidney News Online and In The Loop are highlighting the top 20 ways the American Society of Nephrology (ASN) and the ASN Foundation for Kidney Research are increasing interest in nephrology careers.

Together, ASN and the ASN Foundation for Kidney Research:

Potential game-changing exchange: Extending coverage for immunosuppressant drugs beyond 3-year limit for patients after a kidney transplant could help Medicare

In a potentially game-changing exchange yesterday at a House Appropriations subcommittee hearing, Health and Human Services (HHS) Secretary Alex M. Azar, II, stated that a preliminary HHS Office of the Actuary analysis indicates that the savings generated by averting dialysis would be greater than the cost required to extend coverage for immunosuppressant drugs. While noting that any potential savings would be “specific to the design of any actual policy,” the Secretary underscored that HHS is “very focused on ways we can incentivize toward transplantation.”

Pages